Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 6
2020 5
2021 5
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Response.
De Sadeleer LJ, Wuyts WA. De Sadeleer LJ, et al. Chest. 2018 Sep;154(3):714-715. doi: 10.1016/j.chest.2018.06.020. Chest. 2018. PMID: 30195350 No abstract available.
Lung Microenvironments and Disease Progression in Fibrotic Hypersensitivity Pneumonitis.
De Sadeleer LJ, McDonough JE, Schupp JC, Yan X, Vanstapel A, Van Herck A, Everaerts S, Geudens V, Sacreas A, Goos T, Aelbrecht C, Nawrot TS, Martens DS, Schols D, Claes S, Verschakelen JA, Verbeken EK, Ackermann M, Decottignies A, Mahieu M, Hackett TL, Hogg JC, Vanaudenaerde BM, Verleden SE, Kaminski N, Wuyts WA. De Sadeleer LJ, et al. Am J Respir Crit Care Med. 2022 Jan 1;205(1):60-74. doi: 10.1164/rccm.202103-0569OC. Am J Respir Crit Care Med. 2022. PMID: 34724391
Real life experience with mTOR-inhibitors after lung transplantation.
Bos S, De Sadeleer LJ, Yserbyt J, Dupont LJ, Godinas L, Verleden GM, Ceulemans LJ, Vanaudenaerde BM, Vos R. Bos S, et al. Among authors: de sadeleer lj. Int Immunopharmacol. 2021 May;94:107501. doi: 10.1016/j.intimp.2021.107501. Epub 2021 Feb 26. Int Immunopharmacol. 2021. PMID: 33647822
Defining and predicting progression in non-IPF interstitial lung disease.
Goos T, De Sadeleer LJ, Yserbyt J, De Langhe E, Dubbeldam A, Verbeken EK, Verleden GM, Vermant M, Verschakelen J, Vos R, Weynand B, Verleden SE, Wuyts WA. Goos T, et al. Among authors: de sadeleer lj. Respir Med. 2021 Nov-Dec;189:106626. doi: 10.1016/j.rmed.2021.106626. Epub 2021 Oct 1. Respir Med. 2021. PMID: 34627007
18 results